🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Human urinary kallidinogenase can promote the establishment of collateral c...
Status
Completed
Location
Department of Neurolgy,Xuanwu Hospital of Capital Medical University
Start Date
2013-01
Trial ID
NCT02259738
Treatments Being Tested
The objective of this study is to evaluate the safety and efficacy of aprot...
Status
Terminated
Location
Multiple Locations
Start Date
2006-02-27
Trial ID
NCT00327379
Treatments Being Tested
This is a 3-part Phase 1 dose-ranging study to evaluate the safety, tolerab...
Status
Completed
Location
Quotient Clinical
Start Date
2015-05
Trial ID
NCT02448264
Treatments Being Tested
Evaluate the effectiveness of the of kallikrein in the different drug frequ...
Status
Unknown
Location
General hospital of shenyang military region
Start Date
2016-11
Trial ID
NCT02806128
Treatments Being Tested
The purpose of this study is to identify the recommended phase 2 combinatio...
Status
Recruiting
Location
Florida Cancer Specialists
Start Date
2025-07-07
Trial ID
NCT07082920
Treatments Being Tested
This study is a multicenter, randomized, double-blind, placebo parallel con...
Status
Not Yet Recruiting
Location
The First Affiliated Hospital, Sun Yat-sen University
Start Date
2024-01-01
Trial ID
NCT06085378
Treatments Being Tested
This study is a multicentre, randomized, blinded-endpoint trial that aims t...
Status
Not Yet Recruiting
Location
China-Japan Union Hospital of Jilin University
Start Date
2026-05-01
Trial ID
NCT07483281
Treatments Being Tested
The purpose of this study is to assess the safety, tolerability, pharmacoki...
Status
Completed
Location
Nanjing Drum Tower Hospital
Start Date
2023-03-16
Trial ID
NCT06380699
Treatments Being Tested
The purpose of this study is to find out whether treatment with pasritamig ...
Status
Recruiting
Location
Arizona Clinical Trials
Start Date
2025-12-19
Trial ID
NCT07225946
Treatments Being Tested
This is a Phase 1 study to investigate the safety, tolerability of the nove...
Status
Completed
Location
Retina Vitreous Associates Medical Group
Start Date
2014-07-18
Trial ID
NCT02193113
Treatments Being Tested